Annual Retained Earnings
-$75.37 M
-$11.12 M-17.31%
December 31, 2023
Summary
- As of February 7, 2025, PCSA annual retained earnings is -$75.37 million, with the most recent change of -$11.12 million (-17.31%) on December 31, 2023.
- During the last 3 years, PCSA annual retained earnings has fallen by -$49.97 million (-196.78%).
- PCSA annual retained earnings is now -7908.62% below its all-time high of -$941.10 thousand, reached on December 31, 2011.
Performance
PCSA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$84.49 M
-$3.38 M-4.17%
September 30, 2024
Summary
- As of February 7, 2025, PCSA quarterly retained earnings is -$84.49 million, with the most recent change of -$3.38 million (-4.17%) on September 30, 2024.
- Over the past year, PCSA quarterly retained earnings has dropped by -$6.39 million (-8.19%).
- PCSA quarterly retained earnings is now -3136.56% below its all-time high of -$2.61 million, reached on September 30, 2012.
Performance
PCSA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PCSA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.3% | -8.2% |
| 3 y3 years | -196.8% | -31.5% |
| 5 y5 years | -888.6% | -31.5% |
PCSA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -104.7% | at low | -129.4% | at low |
| 5 y | 5-year | -586.3% | at low | -669.4% | at low |
| alltime | all time | -7908.6% | at low | -3136.6% | at low |
Processa Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$84.49 M(+4.2%) |
| Jun 2024 | - | -$81.11 M(+3.9%) |
| Mar 2024 | - | -$78.10 M(+3.6%) |
| Dec 2023 | -$75.37 M(+17.3%) | -$75.37 M(+3.3%) |
| Sep 2023 | - | -$72.96 M(+2.9%) |
| Jun 2023 | - | -$70.88 M(+3.8%) |
| Mar 2023 | - | -$68.27 M(+6.3%) |
| Dec 2022 | -$64.25 M(+74.5%) | -$64.25 M(+25.4%) |
| Sep 2022 | - | -$51.24 M(+13.3%) |
| Jun 2022 | - | -$45.21 M(+12.9%) |
| Mar 2022 | - | -$40.05 M(+8.8%) |
| Dec 2021 | -$36.82 M(+45.0%) | -$36.82 M(+9.5%) |
| Sep 2021 | - | -$33.64 M(+9.7%) |
| Jun 2021 | - | -$30.65 M(+11.5%) |
| Mar 2021 | - | -$27.50 M(+8.3%) |
| Dec 2020 | -$25.40 M(+131.2%) | -$25.40 M(+62.2%) |
| Sep 2020 | - | -$15.66 M(+24.4%) |
| Jun 2020 | - | -$12.59 M(+6.2%) |
| Mar 2020 | - | -$11.86 M(+8.0%) |
| Dec 2019 | -$10.98 M(+44.0%) | -$10.98 M(+7.6%) |
| Sep 2019 | - | -$10.21 M(+9.2%) |
| Jun 2019 | - | -$9.34 M(+11.6%) |
| Mar 2019 | - | -$8.38 M(+9.8%) |
| Dec 2018 | -$7.62 M | -$7.62 M(+8.7%) |
| Sep 2018 | - | -$7.01 M(+13.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -$6.16 M(+24.3%) |
| Mar 2018 | - | -$4.96 M(+28.4%) |
| Dec 2017 | -$3.86 M(-74.7%) | -$3.86 M(-77.3%) |
| Sep 2017 | - | -$17.04 M(+10.7%) |
| Jun 2017 | - | -$15.39 M(+0.3%) |
| Mar 2017 | - | -$15.34 M(+0.6%) |
| Dec 2016 | -$15.25 M(+2.6%) | -$15.25 M(+0.7%) |
| Sep 2016 | - | -$15.15 M(+0.5%) |
| Jun 2016 | - | -$15.07 M(+0.4%) |
| Mar 2016 | - | -$15.02 M(+1.0%) |
| Dec 2015 | -$14.87 M(+25.5%) | -$14.87 M(-6.6%) |
| Sep 2015 | - | -$15.93 M(+2.0%) |
| Jun 2015 | - | -$15.62 M(+15.2%) |
| Mar 2015 | - | -$13.56 M(+14.4%) |
| Dec 2014 | -$11.85 M(+73.9%) | -$11.85 M(+18.5%) |
| Sep 2014 | - | -$10.00 M(+9.5%) |
| Jun 2014 | - | -$9.13 M(+11.1%) |
| Mar 2014 | - | -$8.22 M(+20.6%) |
| Dec 2013 | -$6.81 M(+98.6%) | -$6.81 M(+14.4%) |
| Sep 2013 | - | -$5.96 M(+18.4%) |
| Jun 2013 | - | -$5.03 M(+17.7%) |
| Mar 2013 | - | -$4.28 M(+24.7%) |
| Dec 2012 | -$3.43 M(+264.6%) | -$3.43 M(+31.4%) |
| Sep 2012 | - | -$2.61 M |
| Dec 2011 | -$941.10 K | - |
FAQ
- What is Processa Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual retained earnings year-on-year change?
- What is Processa Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly retained earnings year-on-year change?
What is Processa Pharmaceuticals annual retained earnings?
The current annual retained earnings of PCSA is -$75.37 M
What is the all time high annual retained earnings for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual retained earnings is -$941.10 K
What is Processa Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, PCSA annual retained earnings has changed by -$11.12 M (-17.31%)
What is Processa Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of PCSA is -$84.49 M
What is the all time high quarterly retained earnings for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly retained earnings is -$2.61 M
What is Processa Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, PCSA quarterly retained earnings has changed by -$6.39 M (-8.19%)